Yury Valdés-Balbín

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero et al. · ACS Chemical Biology · 2021 · 88 citations · Full text

Vaccination, Vaccine Development, Virus Infection +13

Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota

Fabrizio Chiodo, Sven C. M. Bruijns, Ernesto Rodríguez et al. · 2020 · 81 citations · Full text

Host Lung Microbiota, Viral Pathogenesis, Glycobiology +18

Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction

Qingju Zhang, Ana Gimeno, Darielys Santana-Mederos et al. · ACS Central Science · 2019 · 69 citations · Full text

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva et al. · The Lancet Regional Health - Americas · 2022 · 44 citations · Full text

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · The Lancet Regional Health - Americas · 2021 · 40 citations · Full text